199 related articles for article (PubMed ID: 26625209)
1. The matricellular protein CYR61 interferes with normal pancreatic islets architecture and promotes pancreatic neuroendocrine tumor progression.
Huang YT; Lan Q; Ponsonnet L; Blanquet M; Christofori G; Zaric J; Rüegg C
Oncotarget; 2016 Jan; 7(2):1663-74. PubMed ID: 26625209
[TBL] [Abstract][Full Text] [Related]
2. VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis.
Inoue M; Hager JH; Ferrara N; Gerber HP; Hanahan D
Cancer Cell; 2002 Mar; 1(2):193-202. PubMed ID: 12086877
[TBL] [Abstract][Full Text] [Related]
3. Suppressive effects of vascular endothelial growth factor-B on tumor growth in a mouse model of pancreatic neuroendocrine tumorigenesis.
Albrecht I; Kopfstein L; Strittmatter K; Schomber T; Falkevall A; Hagberg CE; Lorentz P; Jeltsch M; Alitalo K; Eriksson U; Christofori G; Pietras K
PLoS One; 2010 Nov; 5(11):e14109. PubMed ID: 21124841
[TBL] [Abstract][Full Text] [Related]
4. Progranulin Stimulates Proliferation of Mouse Pancreatic Islet Cells and Is Overexpressed in the Endocrine Pancreatic Tissue of an MEN1 Mouse Model.
Barbu A; Lejonklou MH; Skogseid B
Pancreas; 2016 Apr; 45(4):533-40. PubMed ID: 26495792
[TBL] [Abstract][Full Text] [Related]
5. Activation of WNT/β-Catenin Signaling Enhances Pancreatic Cancer Development and the Malignant Potential Via Up-regulation of Cyr61.
Sano M; Driscoll DR; DeJesus-Monge WE; Quattrochi B; Appleman VA; Ou J; Zhu LJ; Yoshida N; Yamazaki S; Takayama T; Sugitani M; Nemoto N; Klimstra DS; Lewis BC
Neoplasia; 2016 Dec; 18(12):785-794. PubMed ID: 27889647
[TBL] [Abstract][Full Text] [Related]
6. Qingyihuaji formula inhibits progress of liver metastases from advanced pancreatic cancer xenograft by targeting to decrease expression of Cyr61 and VEGF.
Yin JH; Shi WD; Zhu XY; Chen Z; Liu LM
Integr Cancer Ther; 2012 Mar; 11(1):37-47. PubMed ID: 21382954
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of vascular endothelial growth factor-A165 enhances tumor angiogenesis but not metastasis during beta-cell carcinogenesis.
Gannon G; Mandriota SJ; Cui L; Baetens D; Pepper MS; Christofori G
Cancer Res; 2002 Jan; 62(2):603-8. PubMed ID: 11809716
[TBL] [Abstract][Full Text] [Related]
8. Increased invasiveness of MMP-9-deficient tumors in two mouse models of neuroendocrine tumorigenesis.
Shchors K; Nozawa H; Xu J; Rostker F; Swigart-Brown L; Evan G; Hanahan D
Oncogene; 2013 Jan; 32(4):502-13. PubMed ID: 22391572
[TBL] [Abstract][Full Text] [Related]
9. 24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor development.
Soncini M; Corna G; Moresco M; Coltella N; Restuccia U; Maggioni D; Raccosta L; Lin CY; Invernizzi F; Crocchiolo R; Doglioni C; Traversari C; Bachi A; Bernardi R; Bordignon C; Gustafsson JÅ; Russo V
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6219-E6227. PubMed ID: 27671648
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer.
Holloway SE; Beck AW; Girard L; Jaber MR; Barnett CC; Brekken RA; Fleming JB
J Am Coll Surg; 2005 Mar; 200(3):371-7. PubMed ID: 15737847
[TBL] [Abstract][Full Text] [Related]
11. Transformation of the microvascular system during multistage tumorigenesis.
Ryschich E; Schmidt J; Hämmerling GJ; Klar E; Ganss R
Int J Cancer; 2002 Feb; 97(6):719-25. PubMed ID: 11857345
[TBL] [Abstract][Full Text] [Related]
12. TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis.
Müller-Hermelink N; Braumüller H; Pichler B; Wieder T; Mailhammer R; Schaak K; Ghoreschi K; Yazdi A; Haubner R; Sander CA; Mocikat R; Schwaiger M; Förster I; Huss R; Weber WA; Kneilling M; Röcken M
Cancer Cell; 2008 Jun; 13(6):507-18. PubMed ID: 18538734
[TBL] [Abstract][Full Text] [Related]
13. Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during beta cell carcinogenesis.
Schomber T; Kopfstein L; Djonov V; Albrecht I; Baeriswyl V; Strittmatter K; Christofori G
Cancer Res; 2007 Nov; 67(22):10840-8. PubMed ID: 18006829
[TBL] [Abstract][Full Text] [Related]
14. The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis.
Huang YT; Lan Q; Lorusso G; Duffey N; Rüegg C
Oncotarget; 2017 Feb; 8(6):9200-9215. PubMed ID: 27911269
[TBL] [Abstract][Full Text] [Related]
15. Matricellular protein Cyr61 bridges lysophosphatidic acid and integrin pathways leading to cell migration.
Wu DD; Zhang F; Hao F; Chun J; Xu X; Cui MZ
J Biol Chem; 2014 Feb; 289(9):5774-83. PubMed ID: 24371135
[TBL] [Abstract][Full Text] [Related]
16. Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma.
Dobroff AS; Wang H; Melnikova VO; Villares GJ; Zigler M; Huang L; Bar-Eli M
J Biol Chem; 2009 Sep; 284(38):26194-206. PubMed ID: 19632997
[TBL] [Abstract][Full Text] [Related]
17. Cyr61 silencing reduces vascularization and dissemination of osteosarcoma tumors.
Habel N; Vilalta M; Bawa O; Opolon P; Blanco J; Fromigué O
Oncogene; 2015 Jun; 34(24):3207-13. PubMed ID: 25065593
[TBL] [Abstract][Full Text] [Related]
18. Cyr61-positive cancer stem-like cells enhances distal metastases of pancreatic cancer.
Shi W; Zhang C; Chen Z; Chen H; Liu L; Meng Z
Oncotarget; 2016 Nov; 7(45):73160-73170. PubMed ID: 27705906
[TBL] [Abstract][Full Text] [Related]
19. CUX1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasms.
Krug S; Kühnemuth B; Griesmann H; Neesse A; Mühlberg L; Boch M; Kortenhaus J; Fendrich V; Wiese D; Sipos B; Friemel J; Gress TM; Michl P
Endocr Relat Cancer; 2014; 21(6):879-90. PubMed ID: 25248790
[TBL] [Abstract][Full Text] [Related]
20. Periostin Limits Tumor Response to VEGFA Inhibition.
Keklikoglou I; Kadioglu E; Bissinger S; Langlois B; Bellotti A; Orend G; Ries CH; De Palma M
Cell Rep; 2018 Mar; 22(10):2530-2540. PubMed ID: 29514082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
